At the validation, a rare recurrent mutation in ATRIP, c.1152_1155del, was observed in 42 of 16,085 Polish breast cancer patients and in 11 of 9285 controls (OR = 2.14, 95% CI = 1.13–4.28, p = 0.02) [7]. This evidence concerns the gene ATRIP and breast carcinoma.